Objectives. The rationale for a routine endoscopy before bariatric surgery in asymptomatic patients remains controversial. The purpose of the present study was to compare, in a retrospective manner, the endoscopic findings of morbidly obese patients awaiting surgery with those of non-obese individuals. Methods. Between January 2014 and December 2014, preoperative endoscopic findings of 161 morbidly obese patients and 101 consecutive non-obese individuals were evaluated. Results. No significant differences were found between the two groups in terms of ulcer prevalence and the number of ulcers (p=0.120 and p=0.122, respectively). However, the frequency of bulbar ulcers was significantly higher in morbidly obese patients than in the nonobese (p=0.012). Furthermore, the ulcer activity score was significantly higher in morbidly obese patients (p=0.025). 84 patients underwent laparoscopic sleeve gastrectomy (LSG). Of those, 48 patients (57.1%) had Helicobacter pylori sero-positivity and 12 patients (14.3%) had peptic ulcer disease before surgery. H. pylori sero-positivity persisted in the resected gastric specimens of 33 patients (39.3%). Conclusion. The ulcer activation score in morbidly obese patients is higher -even when they are asymptomatic-than in non-obese individuals. Routine preoperative endoscopy should be considered in all bariatric surgery candidates to rule out pathologies such as hiatal hernia, extensive ulcers or malignant lesions which are the contraindications for a LSG.
Introduction
Obesity is an increasingly serious health problem in both developed and developing countries. Bariatric surgery has proven to be the most effective treatment for morbid obesity. Published guidelines from the European Association for Endoscopic Surgery (EAES) in 2005 and the American Society of Gastroenterology (ASGE) in 2008 recommended that upper gastrointestinal endoscopy should be performed in all symptomatic patients undergoing bariatric surgery, and considered in all candidates [1, 2] . However, the rationale for using routine endoscopy in asymptomatic patients before bariatric surgery remains contentious [3] [4] [5] [6] [7] [8] [9] [10] . Several authors have now documented the lack of correlation between patient symptoms and endoscopic findings and have suggested that routine preoperative endoscopy might in fact be useful in detecting both lesions and inflammation [11, 12] . Besides, there is no long-term data available after sleeve gastrectomy, reflux esophagitis and/or hiatal hernia may contraindicate this operation, especially since the absence of preoperative symptoms cannot be relied upon.
The purpose of the present study was to compare endoscopic findings of morbidly obese patients awaiting surgery with non-obese individuals.
Methods
Between January 2014 and December 2014, upper endoscopy was performed in 101 consecutive nonobese patients (control group) and 161 morbidly obese patients (morbid obesity group) who were referred for endoscopy prior to bariatric surgery. Endoscopic findings and histopathological signs were analyzed retrospectively after approval from the local Ethical Committee of Bursa Yuksek Ihtisas Training and Research Hospital. All endoscopic procedures were performed by the same gastroenterologist and fourquadrant biopsies were taken from the gastric antrum. Additional biopsies were also taken in areas of mucosal surface irregularity. Routine screening for Helicobacter pylori positivity was carried out both in preoperative endoscopies and on the resected gastric specimens. The only patients placed on H. pylori eradication therapy were those displaying peptic ulcer disease during preoperative endoscopy: asymptomatic patients or patients with no endoscopic evidence of ulcers were not given the medication consisting of clarithromycin + amoxicillin+ proton pump inhibitor, regardless of their H. pylori positivity. Histopathological evaluation of the biopsy specimens was carried out by a single pathologist and according to the Sydney classification schema.
In the morbidly obese group, patients with a body mass index (BMI) ≥40mg/m 2 as well as patients with BMI ≥35kg/m 2 but with additional co-morbidities (diabetes mellitus, hypertension, chronic obstructive respiratory disease, etc.) were included in the study. A hiatal hernia was defined endoscopically as more than 2 cm separation of the upwardly displaced esophagogastric junction and the diaphragmatic impression.
Statistical Analysis
Data analysis was performed using SPSS for Windows, version 11. 
Results
Eighty-four morbidly obese patients had undergone LSG and 77 patients were on the waiting list for bariatric surgery. None of them had obvious symptomatic dyspeptic complaints, but all were scheduled for a routine endoscopy prior to the surgical intervention. The median age in non-obese patients (the control group) was 34 years (min-max: 22-52) . The female/male ratio was significantly higher in the morbid obesity group when compared to the control group (p<0.001). There was no significant difference between the two groups according to the status of the lower esophageal sphincter (LES) with regard to normal range or weaker pressure (p=0.990) ( Table 1) .
Although no significant differences were found between the two groups in terms of ulcer prevalence or the number of ulcers (p=0.120, p=0.122), the localization of ulcers were significantly different between the two groups (p=0.008) and the frequency of bulbar ulcers was significantly higher in the morbid obesity group when compared to the control group (p=0.012). The frequency of bulbitis or alkaline reflux gastritis did not significantly differ between the two groups (p=0.547, p=0.377). On the other hand, the frequency of esophagitis was significantly lower in the morbid obesity group when compared to the control group (p=0.021) ( Table 2) .
The prevalence of additional pathologies and the frequency of hiatal hernia were significantly higher in the control group (p=0.004, p=0.049) ( Table 3) .
The distribution of H. pylori grading and the severity of inflammation revealed no significant difference between the two groups (p=0.171, p=0.581). However, the ulcer activity scores were found to be significantly higher in the morbid obesity group (p=0.025). The incidence of gastric atrophy was also higher in the morbid obesity group, but the difference was not statistically significant (p=0.212). No significant difference was found between the two groups according to the distribution of metaplasia or the severity and incidence of dysplasia (p=0.238, p=1.000) ( Table 4) . The H. pylori sero-positivity was found in 75 patients (74.25%) of 101 non obese patients. Of the 84 patients who underwent LSG, H. pylori was detected in the preoperative endoscopic biopsies of 48 patients (57.1%). H. pylori positivity continued in the resected gastric specimens of 33 patients (39.3%). Peptic ulcer disease was found with preoperative endoscopy in 12 of the 84 patients receiving LSG and these patients were placed on eradication therapy. Of these 12 patients, 6 were H. pylori sero-negative both preoperatively and postoperatively; 3 patients were H. pylori sero-positive both pre-and postoperatively; and in the remaining 3 patients, H. pylori was eradicated and not detected in the gastric specimen (Table 5) . Control endoscopy was not performed after eradication treatment.
Postoperative complications after LSG developed in 5 of the 84 patients (5.96%). In 2 patients there was postoperative bleeding from the stapler line: one had multiple gastric ulcers and the other a pre-pyloric ulcer. However, both patients were preoperatively asymptomatic and H. pylori sero-negative. Wound infection occurred in two patients with positive H. pylori infection and the last remaining patient had a liver subcapsular abscess which was H. pylori seropositivite preoperatively.
Discussion
Peptic ulcer disease is strongly associated with H. pylori infection and, when present, eradication of H. pylori reduces ulcer recurrence. However, the prevalence of H. pylori infection in morbidly obese patients and its effect on ulcer progression or the response to eradication treatments is unresolved [13] [14] [15] [16] [17] [18] . Furthermore, it is also unclear whether the detection and eradication of H. pylori prior to bariatric surgery can reduce the risk of postoperative peptic ulcer disease [19, 20] . These dilemmas are not surprising when we consider the variation in H. pylori prevalence according to geographical region, which is influenced by socio-economic environments and eating habits. The lack of large randomized controlled studies precludes a definite conclusion. In the present study, H. pylori infection and its related dyspeptic complaints were high in both morbidly obese and non-obese patients which is similar with the results of Ozden et al. [21] who studied the sero-epidemiology of H. pylori in Turkish population. For this reason, upper endoscopy is performed routinely in our clinic prior to bariatric surgery. Subsequently, all our morbidly obese patients with dyspeptic symptoms or peptic ulcer disease, confirmed by histopathological examination after upper endoscopy, are placed on a standard six-week H. pylori eradication treatment before surgery.
96
Results of the present study indicate that the existence of H. pylori sero-positivity does not seem to have a negative impact on early postoperative outcome after LSG. However, long term effects of H. pylori sero-positivity on the gastric pouch with a risk of cancer development remains unknown. Another noteworthy point is the high ulcer activity scores in morbidly obese patients. Additionally, bulbar ulcers were significantly more frequent in morbidly obese patients than in the non-obese. Remarkably, H. pylori positivity was less frequently found in resected gastric specimens than in the preoperative endoscopic biopsies. This may be related to the localization of H. pylori and suggest that the presence of H. pylori continues in gastric pouches well after LSG. Finally, it is of interest that all of the patients with peptic ulcer disease were asymptomatic before endoscopy. In the light of these findings, we recommend routine H. pylori eradication therapy before bariatric surgery not only in those with peptic ulcer disease but also in H. pylori sero-positive patients.
The Limitations of the Study
The present study has several limitations. Firstly, upper endoscopy was performed in our control group patients for a variety of dyspeptic complaints, whereas all morbid obesity patients preparing for surgery underwent routine endoscopy, and this may have distorted the true prevalence of H. pylori in healthy individuals. Secondly, postoperative long-term followup is not available and the sample size is too small to conclude whether the H. pylori eradication treatment has had an impact on the reduction of postoperative ulcer recurrence in morbidly obese patients.
Conclusions
Our results indicate that H. pylori sero-positivity does not seem to significantly alter early postoperative outcome. However, long term effects of H. pylori seropositivity on the gastric pouch with a risk of cancer development remains unknown. The ulcer activation score in morbidly obese patients is higher -even when they are asymptomatic-than in non-obese individuals. Routine preoperative endoscopy should be considered in all bariatric surgery candidates to rule out pathologies such as hiatal hernia, extensive ulcers or malignant lesions which are contraindications for a LSG.
